This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;81(1):e45-e50.
doi: 10.1016/j.jinf.202004005. Epub 2020 Apr 14.

Saliva is a reliable tool to detect SARS-CoV-2

Affiliations

Saliva is a reliable tool to detect SARS-CoV-2

Lorenzo Azzi et al. J Infect. 2020 Jul.

Abstract

Objectives: This study analyzed salivary samples of COVID-19 patients and compared the results with their clinical and laboratory data.

Methods: Salivary samples of 25 COVID-19 patients were analyzed by rRT-PCR. The following data were collected: age, sex, comorbidities, drugs. Lactate dehydrogenase (LDH) and ultrasensitive reactive C protein (usRCP) values were registered on the same day when a salivary swab was collected. Prevalence of positivity in saliva and association between clinical data and the cycle threshold as a semiquantitative indicator of viral load were considered.

Results: Twenty-five subjects were recruited into this study, 17 males and 8 females. The mean age was 61.5 +/- 11.2 years. Cardiovascular and/or dysmetabolic disorders were observed in 65.22% of cases. All the samples tested positive for the presence of SARS-CoV-2, while there was an inverse association between LDH and Ct values. Two patients showed positive salivary results on the same days when their pharyngeal or respiratory swabs showed conversion.

Conclusions: Saliva is a reliable tool to detect SARS-CoV-2. The role of saliva in COVID-19 diagnosis could not be limited to a qualitative detection of the virus, but it may also provide information about the clinical evolution of the disease.

Keywords: COVID-19; Coronavirus; SARS-CoV-2; Saliva; nCoV-2019.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interests None.

Figures

Fig 1
Fig. 1
Scatter plot of LDH (a) or usCRP (c) values on the rRT-PCR cycle threshold values. Women and men are indicated by red and blue points; the blue line represents the regression result and the light blue area is its 95% confidence intervals. Panels (b) and (d) showed the same plots using age- and sex-adjusted residuals of LDH and usCRP levels, respectively, instead of their measured values, and the regression result from age- and sex-adjusted analysis (Table 2). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Comment in

References

    1. World Health Organization2019-nCoV Situation report – 1 21 January 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
    1. Lu H., Stratton C.W., Tang Y.-W. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92:401–402. - PMC - PubMed
    1. Rehman S.U., Shafique L., Ihsan A. Evolutionary trajectory for the emergence of a Novel Coronavirus SARS-CoV-2. Pathogens. 2020;9(3) doi: 10.3390/pathogens9030240. - DOI - PMC - PubMed
    1. Lupia T., Scabini S., Mornese Pinna S. 2019 novel coronavirus (2019-nCoV) outbreak: a new challenge. J Glob Antimicrob Resist. 2020;21:22–27. - PMC - PubMed
    1. Centers for Disease Control and Prevention (CDC) Update: novel influenza A (H1N1) virus infections – worldwide,Mmay 6, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:453–458. - PubMed
Cite

AltStyle によって変換されたページ (->オリジナル) /